BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 35444026)

  • 41. Hyperthecosis: an underestimated nontumorous cause of hyperandrogenism.
    Meczekalski B; Szeliga A; Maciejewska-Jeske M; Podfigurna A; Cornetti P; Bala G; Adashi EY
    Gynecol Endocrinol; 2021 Aug; 37(8):677-682. PubMed ID: 33759685
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hirsutism and virilism in women.
    Kirschner MA
    Spec Top Endocrinol Metab; 1984; 6():55-93. PubMed ID: 6084314
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Exploring the unusual: a testosterone-secreting ovarian tumor.
    Kaur H; Singh N; Bharti S; Kaur G
    Autops Case Rep; 2024; 14():e2024478. PubMed ID: 38487035
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Accessory ovarian steroid cell tumor producing testosterone and cortisol: A case report.
    Zang L; Ye M; Yang G; Li J; Liu M; Du J; Gu W; Jin N; Yang L; Ba J; Dou J; Fan W; Mu Y; Meng Y; Lyu Z
    Medicine (Baltimore); 2017 Sep; 96(37):e7998. PubMed ID: 28906379
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diffuse stromal Leydig cell hyperplasia: a unique cause of postmenopausal hyperandrogenism and virilization.
    Taylor HC; Pillay I; Setrakian S
    Mayo Clin Proc; 2000 Mar; 75(3):288-92. PubMed ID: 10725957
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ovarian Leydig cell tumor in a peri-menopausal woman with severe hyperandrogenism and virilization.
    Nardo LG; Ray DW; Laing I; Williams C; McVey RJ; Seif MW
    Gynecol Endocrinol; 2005 Oct; 21(4):238-41. PubMed ID: 16316848
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Virilising ovarian tumour in a woman with an adrenal nodule.
    Rivera-Arkoncel ML; Pacquing-Songco D; Lantion-Ang FL
    BMJ Case Rep; 2010 Dec; 2010():. PubMed ID: 22802276
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Virilization due to ovarian hyperthecosis in a postmenopausal woman.
    van Heyningen C; MacFarlane IA; Diver MJ; Muronda C; Tuffnell D
    Gynecol Endocrinol; 1988 Dec; 2(4):331-8. PubMed ID: 3232554
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hypothyroidism and hyperlipidemia with a virilizing ovarian steroid cell tumor, not otherwise specified.
    Tsai HJ; Chen SC; Wei HY; Chen GD
    Gynecol Endocrinol; 2007 Feb; 23(2):69-71. PubMed ID: 17454154
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hyperandrogenism due to ovarian Leydig cell tumour presenting with polycythaemia.
    Demir AY; Blok BB; Brinkhuis EA; Oldenburg-Ligtenberg CP
    BMJ Case Rep; 2022 Jul; 15(7):. PubMed ID: 35840164
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Hyperandrogenism in women].
    Peigné M; Villers-Capelle A; Robin G; Dewailly D
    Presse Med; 2013 Nov; 42(11):1487-99. PubMed ID: 24184282
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hyperandrogenism of ovarian etiology: utilizing differential venous sampling for diagnosis.
    Bailey AP; Schutt AK; Carey RM; Angle JF; Modesitt SC
    Obstet Gynecol; 2012 Aug; 120(2 Pt 2):476-479. PubMed ID: 22825271
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ovarian steroid cell tumor (not otherwise specified) with subsequent spontaneous pregnancy after tumor removal: a case report and literature review.
    Matemanosak P; Peeyananjarassri K; Suwanrath C; Wattanakumtornkul S; Klangsin S; Thiangphak E; Kanjanapradit K
    Gynecol Endocrinol; 2023 Dec; 39(1):2186138. PubMed ID: 36878245
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A large ovarian steroid cell tumor-not otherwise specified with a unique combination of benign and malignant features as a challenging cause of oligomenorrhea and hirsutism in a 21-year-old Syrian female: a case report.
    Ismail S; Hraib M; Issa R; Alassi T; Alshehabi Z
    BMC Womens Health; 2021 Mar; 21(1):95. PubMed ID: 33663470
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lipid cell tumor in an adolescent girl: a case report.
    Ding DC; Hsu S
    J Reprod Med; 2007 Oct; 52(10):956-8. PubMed ID: 17977174
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ovarian steroid cell tumour (NOS) causing Cushing's syndrome in an extremely young girl: A case report.
    Hellyanti T; Sitinjak D
    J Pak Med Assoc; 2021 Feb; 71(Suppl 2)(2):S146-S150. PubMed ID: 33785961
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The case of the elusive androgen.
    Cobin RH
    Endocr Pract; 2002; 8(6):433-8. PubMed ID: 15260009
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Postmenopausal hyperthecosis: functional dysregulation of androgenesis in climacteric ovary.
    Krug E; Berga SL
    Obstet Gynecol; 2002 May; 99(5 Pt 2):893-7. PubMed ID: 11975949
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Symptomatic Cushing's syndrome and hyperandrogenemia in a steroid cell ovarian neoplasm: a case report.
    Sedhom R; Hu S; Ohri A; Infantino D; Lubitz S
    J Med Case Rep; 2016 Oct; 10(1):278. PubMed ID: 27729065
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical Case Seminar: Postmenopausal androgen excess-challenges in diagnostic work-up and management of ovarian thecosis.
    Mamoojee Y; Ganguri M; Taylor N; Quinton R
    Clin Endocrinol (Oxf); 2018 Jan; 88(1):13-20. PubMed ID: 28980338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.